Connect with us

Health

Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – THE WEEK

What is very clear is that two doses are required to maximise protection

Published

on

Article feature image
ADVERTISEMENT

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending